Literature DB >> 21439108

Co-morbidity between major depressive disorder and anxiety disorders: shared etiology or direct causation?

A R Mathew1, J W Pettit, P M Lewinsohn, J R Seeley, R E Roberts.   

Abstract

BACKGROUND: Major depressive disorder (MDD) and anxiety disorders (ANX) are debilitating and prevalent conditions that often co-occur in adolescence and young adulthood. The leading theoretical models of their co-morbidity include the direct causation model and the shared etiology model. The present study compared these etiological models of MDD-ANX co-morbidity in a large, prospective, non-clinical sample of adolescents tracked through age 30.
METHOD: Logistic regression was used to examine cross-sectional associations between ANX and MDD at Time 1 (T1). In prospective analyses, Cox proportional hazards models were used to examine T1 predictors of subsequent disorder onset, including risk factors specific to each disorder or common to both disorders. Prospective predictive effect of a lifetime history of one disorder (e.g. MDD) on the subsequent onset of the second disorder (e.g. ANX) was then examined. This step was repeated while controlling for common risk factors.
RESULTS: The findings supported relatively distinct profiles of risk between MDD and ANX depending on order of development. Whereas the shared etiology model best explained co-morbid cases in which MDD preceded ANX, direct causation was supported for co-morbid cases in which ANX preceded MDD.
CONCLUSIONS: Consistent with previous research, significant cross-sectional and prospective associations were found between MDD and ANX. The results of the present study suggest that different etiological models may characterize the co-morbidity between MDD and ANX based upon the temporal order of onset. Implications for classification and prevention efforts are discussed.

Entities:  

Mesh:

Year:  2011        PMID: 21439108      PMCID: PMC3713851          DOI: 10.1017/S0033291711000407

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  84 in total

Review 1.  Comorbidity.

Authors:  A Angold; E J Costello; A Erkanli
Journal:  J Child Psychol Psychiatry       Date:  1999-01       Impact factor: 8.982

2.  Explained randomness in proportional hazards models.

Authors:  John O'Quigley; Ronghui Xu; Janez Stare
Journal:  Stat Med       Date:  2005-02-15       Impact factor: 2.373

3.  Treatment of children with antidepressants: focus on selective serotonin reuptake inhibitors.

Authors:  G J Emslie; W A Weinberg; T L Mayes
Journal:  Depress Anxiety       Date:  1998       Impact factor: 6.505

4.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

5.  Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression.

Authors:  D A Brent; D J Kolko; B Birmaher; M Baugher; J Bridge; C Roth; D Holder
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1998-09       Impact factor: 8.829

6.  Rethinking the mood and anxiety disorders: a quantitative hierarchical model for DSM-V.

Authors:  David Watson
Journal:  J Abnorm Psychol       Date:  2005-11

7.  Subthreshold depression in adolescence and mental health outcomes in adulthood.

Authors:  David M Fergusson; L John Horwood; Elizabeth M Ridder; Annette L Beautrais
Journal:  Arch Gen Psychiatry       Date:  2005-01

8.  The cost of treating anxiety: the medical and demographic correlates that impact total medical costs.

Authors:  Martin D Marciniak; Maureen J Lage; Eduardo Dunayevich; James M Russell; Lee Bowman; Ronald P Landbloom; Louise R Levine
Journal:  Depress Anxiety       Date:  2005       Impact factor: 6.505

Review 9.  Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications.

Authors:  P M Lewinsohn; P Rohde; J R Seeley
Journal:  Clin Psychol Rev       Date:  1998-11

10.  A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.

Authors:  L L Judd; H S Akiskal; J D Maser; P J Zeller; J Endicott; W Coryell; M P Paulus; J L Kunovac; A C Leon; T I Mueller; J A Rice; M B Keller
Journal:  Arch Gen Psychiatry       Date:  1998-08
View more
  43 in total

1.  Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys.

Authors:  R C Kessler; N A Sampson; P Berglund; M J Gruber; A Al-Hamzawi; L Andrade; B Bunting; K Demyttenaere; S Florescu; G de Girolamo; O Gureje; Y He; C Hu; Y Huang; E Karam; V Kovess-Masfety; S Lee; D Levinson; M E Medina Mora; J Moskalewicz; Y Nakamura; F Navarro-Mateu; M A Oakley Browne; M Piazza; J Posada-Villa; T Slade; M Ten Have; Y Torres; G Vilagut; M Xavier; Z Zarkov; V Shahly; M A Wilcox
Journal:  Epidemiol Psychiatr Sci       Date:  2015-02-27       Impact factor: 6.892

2.  The latent structure and comorbidity patterns of generalized anxiety disorder and major depressive disorder: a national study.

Authors:  Carlos Blanco; José M Rubio; Melanie Wall; Roberto Secades-Villa; Katja Beesdo-Baum; Shuai Wang
Journal:  Depress Anxiety       Date:  2013-06-14       Impact factor: 6.505

3.  Escalation to Major Depressive Disorder among adolescents with subthreshold depressive symptoms: evidence of distinct subgroups at risk.

Authors:  Ryan M Hill; Jeremy W Pettit; Peter M Lewinsohn; John R Seeley; Daniel N Klein
Journal:  J Affect Disord       Date:  2014-02-10       Impact factor: 4.839

4.  Social context and the real-world consequences of social anxiety.

Authors:  Juyoen Hur; Kathryn A DeYoung; Samiha Islam; Allegra S Anderson; Matthew G Barstead; Alexander J Shackman
Journal:  Psychol Med       Date:  2019-08-19       Impact factor: 7.723

5.  Anxiety disorders in adolescents and psychosocial outcomes at age 30.

Authors:  Cecilia A Essau; Peter M Lewinsohn; Beatriz Olaya; John R Seeley
Journal:  J Affect Disord       Date:  2014-01-02       Impact factor: 4.839

6.  Why are anxiety and depressive symptoms comorbid in youth? A multi-wave, longitudinal examination of competing etiological models.

Authors:  Joseph R Cohen; Jami F Young; Brandon E Gibb; Benjamin L Hankin; John R Z Abela
Journal:  J Affect Disord       Date:  2014-03-13       Impact factor: 4.839

7.  Social criticism moderates the relationship between anxiety and depression 10 years later.

Authors:  Kayla A Lord; Nicholas C Jacobson; Michael K Suvak; Michelle G Newman
Journal:  J Affect Disord       Date:  2020-05-21       Impact factor: 4.839

Review 8.  Comorbidity of anxiety and depression in children and adolescents: 20 years after.

Authors:  Colleen M Cummings; Nicole E Caporino; Philip C Kendall
Journal:  Psychol Bull       Date:  2013-11-11       Impact factor: 17.737

9.  Attention-deficit/hyperactivity disorder in adolescence predicts onset of major depressive disorder through early adulthood.

Authors:  Michael C Meinzer; Peter M Lewinsohn; Jeremy W Pettit; John R Seeley; Jeff M Gau; Andrea Chronis-Tuscano; James G Waxmonsky
Journal:  Depress Anxiety       Date:  2013-02-19       Impact factor: 6.505

10.  Is liability to recurrent major depressive disorder present before first episode onset in adolescence or acquired after the initial episode?

Authors:  Jeremy W Pettit; Chelsey Hartley; Peter M Lewinsohn; John R Seeley; Daniel N Klein
Journal:  J Abnorm Psychol       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.